HELE Stock Analysis: Helen of Troy | NASDAQ

Kitchen Utensils, Insulated Drinkware, Hair Appliances, Outdoor Packs

Total Rating 67

Safety 86

Buy Signal 1.23

Household & Personal Products
Industry Rotation: +20.8

Market Cap: 668M
Avg Turnover: 15.2M

Risk 3d forecast

Volatility51.9%

VaR 5^th Pctl8.10%

VaR vs Median-4.67%

Reward TTM

Sharpe Ratio0.89

Rel. Str. IBD90.5

Rel. Str. Peer Group93.6 pctl

Character TTM

Beta1.761

Beta Downside1.974

Hurst Exponent0.463

Choppyness70.5%

Drawdowns 3y

Max DD89.01%

CAGR/Max DD-0.39

CAGR/Mean DD-0.61

EPS (Earnings per Share)

EPS CAGR: -33.54%
EPS Trend: -93.7%

Last SUE: 1.44
Qual. Beats: 1

Revenue

Rev. CAGR: -4.12%
Rev. Trend: -93.9%

Last SUE: -0.09
Qual. Beats: 0

Warnings

High Debt/EBITDA With Thin Interest Coverage

Interest Coverage Ratio Critical

Fakeout

Tailwinds

Rs Leader

Confidence

Tailwind

Pullback 52w

Seasonality 11.7 years of data

Jan -1.6% 8

Feb -0.1% 5

Mar -4.7% 33

Apr +5.9% 20

May -0.4% 5

Jun +2.4% 8

Jul -3.6% 20

Aug +2.2% 5

Sep -0.3% 2

Oct -5.4% 41

Nov +7.1% 66

Dec +5.7% 42

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: HELE Helen of Troy

Helen of Troy Limited is a multi-brand consumer products company headquartered in El Paso, Texas, operating across North America, Europe, the Middle East, Africa, Asia Pacific, and Latin America. The company is organized into two reporting segments: Home & Outdoor, which covers kitchen tools, food storage, insulated beverageware, hydration packs, luggage, and outdoor bags; and Beauty & Wellness, which includes hair care appliances and styling products, nail care, grooming tools, and home health devices such as thermometers, blood pressure monitors, and water and air filtration systems. Products are sold through a broad retail network spanning mass merchandisers, drugstores, sporting goods retailers, department stores, grocers, specialty and prestige beauty chains, e-commerce platforms, warehouse clubs, and distributors, as well as directly to consumers.

The company markets products under a portfolio of owned and licensed brands, including OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools, Drybar, Curlsmith, Revlon, and Olive & June. As a small-cap issuer in the Consumer Discretionary sector classified under Household Appliances, Helen of Troy follows a house-of-brands model, acquiring and operating distinct brand identities across unrelated product categories rather than building a single unified brand, which allows it to target different price points and retail channels simultaneously.

Headlines to Watch Out For

Revlon integration drags Beauty segment margins
Hydro Flask and Osprey drive Home & Outdoor growth
China tariff exposure pressures product margins

Piotroski VR-10 (Strict) 5.5

Net Income: -99.2m TTM > 0 and > 6% of Revenue
FCF/TA: 0.07 > 0.02 and ΔFCF/TA 3.58 > 1.0
NWC/Revenue: 18.91% < 20% (prev 21.33%; Δ -2.42% < -1%)
CFO/TA 0.09 > 3% & CFO 179.7m > Net Income -99.2m
Net Debt (811.0m) to EBITDA (79.1m): 10.25 < 3
Current Ratio: 1.65 > 1.5 & < 3
Outstanding Shares: last quarter (24.2m) vs 12m ago 5.20% < -2%
Gross Margin: 47.37% > 18% (prev 47.30%; Δ 0.07% > 0.5%)
Asset Turnover: 81.08% > 50% (prev 75.60%; Δ 5.48% > 0%)
Interest Coverage Ratio: 0.51 > 6 (EBIT TTM 26.3m / Interest Expense TTM 51.9m)

Altman Z'' 2.59

A: 0.16 (Total Current Assets 876.3m - Total Current Liabilities 531.0m) / Total Assets 2.10b
B: 0.22 (Retained Earnings 453.2m / Total Assets 2.10b)
C: 0.01 (EBIT TTM 26.3m / Avg Total Assets 2.25b)
D: 0.69 (Book Value of Equity 853.8m / Total Liabilities 1.24b)
Altman-Z'' = 2.59 = A

Beneish M -3.15

DSRI: 0.93 (Receivables 334.9m/357.1m, Revenue 1.83b/1.82b)
GMI: 1.00 (GM 47.30% / 47.37%)
AQI: 0.90 (AQ_t 0.41 / AQ_t-1 0.46)
SGI: 1.00 (Revenue 1.83b / 1.82b)
TATA: -0.13 (NI -99.2m - CFO 179.7m) / TA 2.10b)
Beneish M = -3.15 (Cap -4..+1) = AA

What is the price of HELE shares?

As of October 18, 2026, the stock is trading at USD 28.99 with a total of 413,354 shares traded. Over the past week, the price has changed by +9.35%, over one month by +5.27%, over three months by +3.17% and over the past year by +52.90%.

Current recommended Stop Loss: 26.80 (which is 7.6% or 1.2 ATR below the current price).

Is HELE a buy, sell or hold?

Helen of Troy has received a consensus analysts rating of 3.25. Therefore, it is recommended to hold HELE.

StrongBuy: 0
Buy: 1
Hold: 3
Sell: 0
StrongSell: 0

What are the forecasts/targets for the HELE price?

Analysts Target Price	31.7	9.2%

Helen of Troy (HELE) - Fundamental Data Overview as of 16 October 2026

Market Cap USD = 667.8m (667.8m USD * 1.0 USD.USD)
P/E Forward = 8.4674
P/S = 0.3657
P/B = 0.8161
P/EG = 0.9718
Revenue TTM = 1.83b USD
EBIT TTM = 26.3m USD
EBITDA TTM = 79.1m USD
Long Term Debt = 755.8m USD (from longTermDebt, last fiscal year)
Short Term Debt = 25.0m USD (from shortTermDebt, last quarter)
Debt = 836.0m USD (corrected: LT Debt 755.8m + ST Debt 25.0m) + Leases 55.2m
Net Debt = 811.0m USD (calculated: Debt 836.0m - CCE 25.0m)
Enterprise Value = 1.48b USD (667.8m + Debt 836.0m - CCE 25.0m)
Interest Coverage Ratio = 0.51 (Ebit TTM 26.3m / Interest Expense TTM 51.9m)
EV/FCF = 10.53x (Enterprise Value 1.48b / FCF TTM 140.5m)
FCF Yield = 9.50% (FCF TTM 140.5m / Enterprise Value 1.48b)
FCF Margin = 7.69% (FCF TTM 140.5m / Revenue TTM 1.83b)
Net Margin = -5.43% (Net Income TTM -99.2m / Revenue TTM 1.83b)
Gross Margin = 47.37% ((Revenue TTM 1.83b - Cost of Revenue TTM 960.9m) / Revenue TTM)
Gross Margin QoQ = 52.19% (prev 45.97%)
Tobins Q-Ratio = 0.71 (Enterprise Value 1.48b / Total Assets 2.10b)
Interest Expense / Debt = 6.21% (Interest Expense 51.9m / Debt 836.0m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 20.8m (EBIT 26.3m * (1 - 21.00%))
Current Ratio = 1.65 (Total Current Assets 876.3m / Total Current Liabilities 531.0m)
Debt / Equity = 0.98 (Debt 836.0m / totalStockholderEquity, last quarter 853.8m)
Debt / EBITDA = 10.25 (Net Debt 811.0m / EBITDA 79.1m)
Debt / FCF = 5.77 (Net Debt 811.0m / FCF TTM 140.5m)
Total Stockholder Equity = 837.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -4.41% (Net Income -99.2m / Total Assets 2.10b)
RoE = -11.86% (Net Income TTM -99.2m / Total Stockholder Equity 837.0m)
RoCE = 1.65% (EBIT 26.3m / Capital Employed (Equity 837.0m + L.T.Debt 755.8m))
RoIC = 1.33% (NOPAT 20.8m / Invested Capital 1.57b)
WACC = 7.86% (E(667.8m)/V(1.50b) * Re(11.55%) + D(836.0m)/V(1.50b) * Rd(6.21%) * (1-Tc(0.21)))
Discount Rate = 11.55% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 48.21 | Cagr: 0.97%
[DCF] Terminal Value 77.97% ; FCFF base≈114.3m ; Y1≈131.1m ; Y5≈192.9m
[DCF] Fair Price = 89.43 (EV 2.90b - Net Debt 811.0m = Equity 2.09b / Shares 23.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -93.65 | EPS CAGR: -33.54% | SUE: 1.44 | # QB: 1
Revenue Correlation: -93.92 | Revenue CAGR: -4.12% | SUE: -0.09 | # QB: 0
EPS current Quarter (2026-11-30): EPS=2.25 | Chg30d=+39.14% | Revisions=+40% | Analysts=4
EPS current Year (2027-02-28): EPS=3.89 | Chg30d=+8.28% | Revisions=+57% | GrowthEPS=+9.6% | GrowthRev=+0.9%
EPS next Year (2028-02-29): EPS=4.04 | Chg30d=+1.09% | Revisions=+0% | GrowthEPS=+4.0% | GrowthRev=+1.5%
[Analyst] Revisions Ratio: +55% (up=7, down=1)